People on Ozempic may have fewer heart attacks, strokes, addictions—but more nausea, vomiting, stomach pain
Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.
Weight-loss drugs: Study involving 2 million people identifies potential benefits beyond obesity treatment and other risks
The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.